{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7224,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a swimmer plot (onco-plot) and a summary table of best overall response (BOR) metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/19",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "before_after",
      "function": "illustrate_case",
      "notes": "The slide uses a timeline to track treatment milestones and CT scans to show tumor reduction from baseline to complete response.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/20",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-20",
      "loopMatches": [
        {
          "to": 21,
          "from": 20,
          "name": "Before After",
          "slug": "21-before-after",
          "bestFor": "Product demos, process improvements, ROI justification",
          "matchId": "ba81daf0-fae5-4421-90e6-9efd4d2dbee9",
          "evidence": "Slides 20-21 present clinical results showing improved treatment outcomes with Nemvaleukin alfa.",
          "position": 1,
          "objective": "How does Nemvaleukin alfa improve treatment outcomes?",
          "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
          "confidence": 0.7,
          "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "59c25a5c-9ce0-4688-9ac5-7b20dd5595fc",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 12-20 present Nemvaleukin alfa as a solution, including its development approach and clinical results.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "Includes a swimmer plot (left) and a summary table (right) with clinical trial metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/21",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-21",
      "loopMatches": [
        {
          "to": 21,
          "from": 20,
          "name": "Before After",
          "slug": "21-before-after",
          "bestFor": "Product demos, process improvements, ROI justification",
          "matchId": "ba81daf0-fae5-4421-90e6-9efd4d2dbee9",
          "evidence": "Slides 20-21 present clinical results showing improved treatment outcomes with Nemvaleukin alfa.",
          "position": 1,
          "objective": "How does Nemvaleukin alfa improve treatment outcomes?",
          "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
          "confidence": 0.7,
          "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "other",
      "function": "present_framework",
      "notes": "The slide outlines a clinical trial protocol with three distinct cohorts and specific dosing schedules.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/22",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "other",
      "function": "present_framework",
      "notes": "Clinical trial design diagram showing randomization, arms, dosing schedules, and endpoints.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/23",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": "The slide uses a hub-and-spoke diagram for the mechanistic combinations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/24",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "other",
      "function": "present_solution",
      "notes": "The slide outlines the clinical strategy for optimizing nemvaleukin dosing, referencing specific clinical trials (ARTISTRY-3 and ARTISTRY-6).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/25",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/26",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "other",
      "function": "establish_context",
      "notes": "The slide uses a process diagram to show the IL-18 signaling cascade (IL-18 -> MYD88 -> IRAK -> NFkB -> IFNy) and a numbered list to detail its immunomodulatory functions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/27",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "problem_statement",
      "function": "diagnose_problem",
      "notes": "Uses a combination of a scatter plot and biological mechanism diagrams to illustrate the inhibitory effect of IL-18BP.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/28",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "before_after",
      "function": "propose_solution",
      "notes": "Uses a before-after-bridge framework to illustrate the mechanism of action for the therapeutic candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/29",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "before_after",
      "function": "analyze_data",
      "notes": "Data shows that while WT IL-18 is inhibited by IL-18BP, the variants are resistant to this inhibition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/30",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "problem_statement",
      "function": "diagnose_problem",
      "notes": "The slide uses a diagram to illustrate the activation of immune cells (NKT, NK, CD4, CD8) by IL-12, leading to IFN-gamma production and subsequent downstream effects.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/31",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": "The slide uses a process flow diagram to explain the therapeutic mechanism.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/32",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": "Includes a bar chart showing dose-dependent PD response in a mouse model and a schematic of the split IL-12 mechanism.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/33",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/34",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a footnote regarding patient enrollment for clinical milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/35",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 35,
          "beatId": "62a80895-2958-4f61-acc3-5b77095f6cea",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Financials",
          "beatSlug": "sequoia-pitch-financials",
          "evidence": "Slides 35-36 provide an overview of Mural Oncology's carve-out financials.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "Uses a numbered list format to highlight key company facts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/36",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 35,
          "beatId": "62a80895-2958-4f61-acc3-5b77095f6cea",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Financials",
          "beatSlug": "sequoia-pitch-financials",
          "evidence": "Slides 35-36 provide an overview of Mural Oncology's carve-out financials.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e341-775b-a82c-decdaeb5c03e",
      "docSlug": "c5ed60c4cc85a094dbae2fa13cb26a34",
      "documentTitle": "Alkermes | Investor Presentation Deck | 37 slides",
      "authorId": "alkermes",
      "authorName": "Mural Oncology",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e341-775b-a82c-decdaeb5c03e/37",
      "deckHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e",
      "deckAnchorHref": "/decks/019de075-e341-775b-a82c-decdaeb5c03e#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/pROiI58Jz7Lzm2TfNS4KGdo_HBm63ExDOSSdJkWavg8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/1",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/7695__bwglmkktd5yPvhWI_h242az0h1oGcOCRL9liI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/JkZVVzsofV7l8OqdRnnkdIH_CtnVDYz8hn8cxha7EVQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/BRN3IMLsiFQ-Qumz-Y5PqLN0O9f5rR6UL1QrCwvpXHk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZDFjYzZiZmQ1M2E5MmNlZjJkNDAzNDdjNWJjMjVlNi9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/2",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/3",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 3,
          "beatId": "5792ec7a-9e33-4e5c-bbed-c0b82b590568",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The presentation starts with a review of Q3 2023 financial performance",
          "position": 0,
          "confidence": 0.7,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide highlights significant growth in revenue and net income metrics year-over-year.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/4",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 3,
          "beatId": "5792ec7a-9e33-4e5c-bbed-c0b82b590568",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The presentation starts with a review of Q3 2023 financial performance",
          "position": 0,
          "confidence": 0.7,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "Includes a blue box highlight around the Q3'23 column.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/5",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes both GAAP and non-GAAP projections, plus specific product revenue breakdowns.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/6",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/7",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The commercial review section highlights topline growth and diversification",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart illustrates the revenue contribution of four specific products (VIVITROL, ARISTADA, VUMERITY, LYBALVI) over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/8",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The commercial review section highlights topline growth and diversification",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "Includes a disclaimer regarding the forward-looking nature of the expectations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/9",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The commercial review section highlights topline growth and diversification",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The chart tracks TRx (Total Prescriptions) over 101 weeks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/10",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The commercial review section highlights topline growth and diversification",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-e430-7299-a96e-811e562ad763",
      "docSlug": "dd1cc6bfd53a92cef2d40347c5bc25e6",
      "documentTitle": "Alkermes | Results Presentation Deck | 27 slides",
      "authorId": "alkermes",
      "authorName": "Alkermes",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-e430-7299-a96e-811e562ad763/11",
      "deckHref": "/decks/019de075-e430-7299-a96e-811e562ad763",
      "deckAnchorHref": "/decks/019de075-e430-7299-a96e-811e562ad763#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 7,
          "beatId": "a4749b6e-fdc8-41ea-a6b7-63976b98f45f",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The commercial review section highlights topline growth and diversification",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}